Table 1.
Clinical characteristics of alloHSCT patients
| n=15 | % | |
|---|---|---|
|
Median age (range) |
57 (28–68) |
|
| <50 |
5 |
30 |
| >50 |
10 |
70 |
| Sex |
|
|
| female |
8 |
53 |
| male |
7 |
47 |
| Diagnosis |
|
|
| AML |
13 |
87 |
| ALL |
2 |
13 |
| Transplant |
|
|
| MUD |
10 |
70 |
| MRD |
5 |
30 |
| Conditioning |
|
|
| full intensity |
8 |
53 |
| 47 reduced intensity |
7 |
47 |
| GvHD (acute = + Chronic) |
|
|
| yes |
16 |
89 |
| no | 2 | 11 |
AML, acute myeloid leukemia; MUD, matched unrelated donor; MRD, matched related donor; GvHD, graft-versus-host disease.